Search
sluggish cognitive tempo
seemingly ill-defined target for ADHD-related drugs [1]
Epidemiology:
- estimated to affect 2 million children, compared with 6 million with ADHD
Clinical manifestations:
- lethargy, daydreaming, & slow mental processing
General
inattention (poor concentration, attention disorder)
learning disorder (learning disability)
References
- Elia J
Physician's First Watch, April 14, 2014
David G. Fairchild, MD, MPH, Editor-in-Chief
Massachusetts Medical Society
http://www.jwatch.org